| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60d2134a44f2b4765a9a1a36828c1d8c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-06012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-16 |
| filingDate |
2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2c4c5711c0aad372b9f18a6ef32cebb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aa9b7c8f9196a302b769fd17081d794
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_468376a337ca536ef413e30962735edc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a169971627bb5821f0fd32f06731233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90478625d5a4cf5bdd4961505132a4c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11cb99a37a7294148746fedc10571ffd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3548c541051dfd2eb9682508accf7695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f7402d4c2417e5a532fcd1469cc1247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a866f17849d957f95f9534c196f5a90 |
| publicationDate |
2005-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6972124-B2 |
| titleOfInvention |
Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| abstract |
The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009017005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572870-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089566-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005287133-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010080720-A2 |
| priorityDate |
2000-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |